This is not the most recent version of the article. View current version (7 OCT 2009)
Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease
Editorial Group: Cochrane Movement Disorders Group
Published Online: 18 JUL 2007
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Caslake R, Macleod A, Ives N, Stowe R, Counsell C. Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD006661. DOI: 10.1002/14651858.CD006661.
- Publication Status: Unchanged
- Published Online: 18 JUL 2007
This is not the most recent version of the article. View current version (07 OCT 2009)
This article has been cited by:
- 1Effects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinsonâ€™s disease, Frontiers in Aging Neuroscience, 2014, 6,, , ,